Live Birth After Additional Tubal Flushing With Oil-based Contrast Versus no Additional Flushing:

PHASE4RecruitingINTERVENTIONAL
Enrollment

736

Participants

Timeline

Start Date

May 25, 2021

Primary Completion Date

April 1, 2025

Study Completion Date

December 1, 2025

Conditions
Infertility, Female
Interventions
DRUG

Lipiodol Ultra Fluide®

Tubal flush with 5-10mL oil-soluble contrast medium (OSCM) (Lipiodol Ultra Fluide®, Guerbet, France) immediately after Hyfosy. The use will be off-label.

Trial Locations (16)

Unknown

RECRUITING

Antwerp University Hospital, Antwerp

RECRUITING

GZA Sint Augustinus, Antwerp

RECRUITING

Imelda, Bonheiden

RECRUITING

AZ Klina, Brasschaat

TERMINATED

AZ Sint Jan Brugge, Bruges

TERMINATED

CHIREC, Brussels

RECRUITING

UCL Saint Luc, Brussels

RECRUITING

UZ Brussel, Brussels

RECRUITING

Ziekenhuis Oost Limburg, Genk

RECRUITING

AZ Sint Lucas, Ghent

RECRUITING

UZ Gent, Ghent

RECRUITING

Hôpital Erasme, Lennik

RECRUITING

UZ Leuven, Leuven

RECRUITING

CHC Mont Légia, Liège

RECRUITING

CHR Citadelle, Liège

RECRUITING

AZ Turnhout, Turnhout

All Listed Sponsors
lead

Dafne Balemans

OTHER